“Autoimmune haemolytic anaemia”的搜索结果，显示 321-330 项，共有 9463 项

1. 血液科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to determine if the drug combination of acalabrutinib, durvalumab, and venetoclax will work to treat Richter's ...

2. 血液科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to evaluate the immune and hematopoietic compartments in patients with monoclonal B cell lymphocytosis (MBL) and ...

3. 血液科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to determine if the drug combination of acalabrutinib, durvalumab, and venetoclax will work to treat Richter's ...

4. 贫血 - 症状与病因 - 妙佑医疗国际

   健康红细胞过少可导致疲倦和无力。该状况有多种类型。

5. 血液科- 临床试验- 妙佑医疗国际

   This phase III trial compares the effect of high dose chemotherapy and the patients' own (autologous) stem cells to observation only in patients with ...

6. 血液科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to evaluate the immune and hematopoietic compartments in patients with monoclonal B cell lymphocytosis (MBL) and ...

7. 血液科- 临床试验- 妙佑医疗国际

   This study is researching an experimental drug called linvoseltamab in combination with other drugs for the treatment of a blood cancer called multiple ...

8. 血液科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to determine if the drug combination of acalabrutinib, durvalumab, and venetoclax will work to treat Richter's ...

9. 血液科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to evaluate the immune and hematopoietic compartments in patients with monoclonal B cell lymphocytosis (MBL) and ...

10. 血液科- 临床试验- 妙佑医疗国际

    Rochester, Minn. The purpose of this study is to determine if the drug combination of acalabrutinib, durvalumab, and venetoclax will work to treat Richter's ...